Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients
| Autor: | Lobanova, Tatiana I. *, Galtseva, Irina V. *, Davydova, Yuliya O. *, Kapranov, Nikolay M. *, Troitskaya, Vera V. *, Lukyanova, Irina A. *, Parovichnikova, Elena *, Kulikov, Sergei M. *, Kuzmina, Larisa *, Savchenko, Valery G. |
|---|---|
| Zdroj: | In Blood 29 November 2018 132 Supplement 1:2808-2808 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|